Phase 1 3 trials
Phase 1
NCT02306629 Nov 2014 → Apr 2015 systemic lupus erythematosus UCB Biopharma S.P.R.L.
Completed
No outcome recorded
Phase 1
NCT00054834 Mar 2003 → ? non-Hodgkin lymphoma Gilead Sciences
Terminated
No outcome recorded
Phase 1
NCT00011908 Feb 2001 → Jan 2003 systemic lupus erythematosus National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Completed
No outcome recorded
Phase 1/2 4 trials
Phase 1/2
NCT01449071 Oct 2011 → Mar 2013 systemic lupus erythematosus UCB Pharma
Completed
No outcome recorded
Phase 1/2
NCT01279707 Jan 2010 → Aug 2014 B-cell acute lymphoblastic leukemia Queen Mary University of London
Unknown
No outcome recorded
Phase 1/2
NCT00098839 Feb 2005 → Apr 2011 childhood acute lymphoblastic leukemia Children's Oncology Group
Completed
No outcome recorded
Phase 1/2
NCT00061425 Aug 2000 → Nov 2007 B-cell non-Hodgkin lymphoma Gilead Sciences
Completed
No outcome recorded
Phase 2 13 trials
Phase 2
NCT01534403 Jan 2012 → Feb 2015 systemic lupus erythematosus UCB Pharma
Completed
No outcome recorded
Phase 2
NCT01219816 Nov 2010 → Nov 2016 B-cell acute lymphoblastic leukemia Nantes University Hospital
Completed
No outcome recorded
Phase 2
NCT00945815 Sep 2010 → Mar 2013 leukemia SWOG Cancer Research Network
Completed
No outcome recorded
Phase 2
NCT00941928 Jul 2009 → May 2012 childhood malignant neoplasm , leukemia M.D. Anderson Cancer Center
Terminated
No outcome recorded
Phase 2
NCT00660881 May 2008 → Dec 2011 systemic lupus erythematosus UCB Pharma
Completed
No outcome recorded
Phase 2
NCT00553501 Mar 2008 → Jul 2010 lymphoma Alliance for Clinical Trials in Oncology
Completed
No outcome recorded
Phase 2
NCT00624351 Jan 2008 → Aug 2009 systemic lupus erythematosus UCB Pharma
Completed
No outcome recorded
Phase 2
NCT00383513 Jun 2006 → Jan 2012 systemic lupus erythematosus UCB Pharma
Completed
No outcome recorded
Phase 2
NCT00301821 Jan 2006 → Oct 2008 lymphoma Alliance for Clinical Trials in Oncology
Completed
No outcome recorded
Phase 2
NCT00113971 Apr 2005 → Mar 2007 systemic lupus erythematosus UCB Pharma
Terminated
No outcome recorded
Phase 2
NCT00113802 Aug 2004 → Dec 2006 Waldenstrom macroglobulinemia Gilead Sciences
Terminated
No outcome recorded
Phase 2
NCT00042913 May 2002 → ? lymphoma Jonsson Comprehensive Cancer Center
Unknown
No outcome recorded
Phase 2
NCT00044902 — non-Hodgkin lymphoma Amgen
Completed
No outcome recorded
Show 3 more trials Phase 3 6 trials
Phase 3
NCT01408576 Jul 2011 → Feb 2016 systemic lupus erythematosus UCB Pharma
Completed
No outcome recorded
Phase 3
NCT01261793 Dec 2010 → May 2015 systemic lupus erythematosus UCB Pharma
Completed
No outcome recorded
Phase 3
NCT01262365 Dec 2010 → May 2015 systemic lupus erythematosus UCB Pharma
Completed
No outcome recorded
Phase 3
NCT00382837 Jan 2007 → ? systemic lupus erythematosus UCB Pharma
Withdrawn
No outcome recorded
Phase 3
NCT00111306 Jun 2005 → Mar 2007 systemic lupus erythematosus UCB Pharma
Terminated
No outcome recorded
Phase 3
NCT00022685 Sep 2001 → ? lymphoma Jonsson Comprehensive Cancer Center
Unknown
No outcome recorded
Phase not applicable 1 trial
— NCT00398372 Nov 2000 → Jun 2007 Waldenstrom macroglobulinemia , diffuse large B-cell lymphoma , mantle cell lymphoma , marginal zone lymphoma +2 Stanford University
Completed
No outcome recorded